The role of clinical microbiology service in antimicrobial stewardship_West China Medical Journal

Authors：

GAO Yulu ¹ , DAI Yuanyuan ² ,  MA Xiaoling ²

1. Depatment of Medical Laboratory, Kunshan Affiliated Hospital of Nanjing University of Chinese Medicine, Kunshan, Jiangsu 215300, P. R. China;
2. Depatment of Medical Laboratory, First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui 230000,P. R. China;

Corresponding author：

MA Xiaoling, Email: maxiaoling@ustc.edu.cn

Keywords：

Clinical microbiology service; Antimicrobial stewardship; Antimicrobial susceptibility test

DOI：

10.7507/1002-0179.202006374

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Inappropriate and irrational prescription of antimicrobial agents has led to increasing bacterial resistance, which has become a major concern around the world. Clinical microbiology service provides a basis and guarantee for the rational application of antimicrobial agents and an important technical support for antimicrobial stewardship, and plays an important role in promoting the rational use of antimicrobial agents. This paper summarizes and evaluates the specific role and technical requirements of clinical microbiology service in the diagnosis of infectious diseases, rational application of antimicrobial agents, hospital infection control and training of medical staff, so as to provide a technical guidance for clinical microbiology service in the antimicrobial stewardship.

Citation： GAO Yulu, DAI Yuanyuan, MA Xiaoling. The role of clinical microbiology service in antimicrobial stewardship. West China Medical Journal, 2020, 35(8): 889-893. doi: 10.7507/1002-0179.202006374 Copy

1.	Aslam B, Wang W, Arshad MI, <italic>et al</italic>. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist, 2018, 11: 1645-1658.
2.	McGann P, Snesrud E, Maybank R, <italic>et al</italic>. Erratum for McGann <italic>et al</italic>., <italic>Escherichia coli</italic> harboring <italic>mcr-1</italic> and <italic>bla</italic><sub>CTX-M</sub> on a novel IncF plasmid: first report of <italic>mcr-1</italic> in the United States. Antimicrob Agents Chemother, 2016, 60(8): 5107.
3.	Hernando-Amado S, Coque TM, Baquero F, <italic>et al</italic>. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol, 2019, 4(9): 1432-1442.
4.	国家卫生和计划生育委员会, 国家发展改革委员会, 教育部, 等. 遏制细菌耐药国家行动计划(2016-2020年). 药物不良反应杂志, 2016, 18(5): 398-400.
5.	中华人民共和国国家卫生和计划生育委员会. 关于持续做好抗菌药物临床应用管理有关工作的通知. 中国实用乡村医生杂志, 2018, 25(6): 1-2.
6.	Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev, 2016, 30(1): 381-407.
7.	中华人民共和国国家健康委员会. 抗菌药物敏感性试验的技术要求: WS/T 639－2018, 2018.
8.	Ashiru-Oredope D, Sharland M, Charani E, <italic>et al</italic>. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1): i51-i63.
9.	中华人民共和国国家健康委员会. 临床微生物学检验标本的采集和转运: WS/T 640－2018, 2018.
10.	中国医师协会检验医师分会感染性疾病检验医学专家委员会, 中国医院协会临床检验管理专业委员会, 中华医学会检验医学分会临床微生物专业学组. 中国三级甲等综合医院检验医学微生物学组(科)建设专家共识. 中华检验医学杂志, 2016, 39(8): 581-584.
11.	马筱玲, 胡继红, 徐英春, 等. 临床微生物学实验室建设基本要求专家共识. 中华检验医学杂志, 2016, 39(11): 820-823.
12.	中国合格评定国家认可委员会. CNAS-CL02-A005: 2018医学实验室质量和能力认可准则在临床微生物检验领域的应用说明. (2018-03-01)[2020-06-01]. https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889106.shtml.
13.	Barenfanger J. Quality assurances: decreasing clinically irrelevant testing from clinical microbiology laboratories, part II. Clin Microbiol Newsl, 2006, 28(4): 25-29.
14.	Dellit TH, Owens RC, Mcgowan JE Jr, <italic>et al</italic>. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis, 2007, 44(2): 159-177.
15.	Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am, 2014, 28(2): 177-193.
16.	Oviaño M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin, 2020: S0213-005X(20)30163-4.
17.	Woo PC, Lau SK, Teng JL, <italic>et al</italic>. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect, 2008, 14(10): 908-934.
18.	Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother, 2020, 75(4): 968-978.
19.	Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin Microbiol Infect, 2019, 25(11): 1347-1355.
20.	Inglis T, Ekelund O. Rapid antimicrobial susceptibility tests for sepsis; the road ahead. J Med Microbiol, 2019, 68(7): 973-977.
21.	Grohs P, Rondinaud E, Fourar M, <italic>et al</italic>. Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. J Microbiol Methods, 2020, 172: 105902.
22.	Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in australian health care 2018. Sydney: Australian Commission on Safety and Quality in Health Care, 2018[2020-06-01]. https://www.safetyandquality.gov.au/publications-and-resources/resource-library/antimicrobial-stewardship-australian-health-care-2018.

1. Aslam B, Wang W, Arshad MI, <italic>et al</italic>. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist, 2018, 11: 1645-1658.
2. McGann P, Snesrud E, Maybank R, <italic>et al</italic>. Erratum for McGann <italic>et al</italic>., <italic>Escherichia coli</italic> harboring <italic>mcr-1</italic> and <italic>bla</italic><sub>CTX-M</sub> on a novel IncF plasmid: first report of <italic>mcr-1</italic> in the United States. Antimicrob Agents Chemother, 2016, 60(8): 5107.
3. Hernando-Amado S, Coque TM, Baquero F, <italic>et al</italic>. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol, 2019, 4(9): 1432-1442.
4. 国家卫生和计划生育委员会, 国家发展改革委员会, 教育部, 等. 遏制细菌耐药国家行动计划(2016-2020年). 药物不良反应杂志, 2016, 18(5): 398-400.
5. 中华人民共和国国家卫生和计划生育委员会. 关于持续做好抗菌药物临床应用管理有关工作的通知. 中国实用乡村医生杂志, 2018, 25(6): 1-2.
6. Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev, 2016, 30(1): 381-407.
7. 中华人民共和国国家健康委员会. 抗菌药物敏感性试验的技术要求: WS/T 639－2018, 2018.
8. Ashiru-Oredope D, Sharland M, Charani E, <italic>et al</italic>. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1): i51-i63.
9. 中华人民共和国国家健康委员会. 临床微生物学检验标本的采集和转运: WS/T 640－2018, 2018.
10. 中国医师协会检验医师分会感染性疾病检验医学专家委员会, 中国医院协会临床检验管理专业委员会, 中华医学会检验医学分会临床微生物专业学组. 中国三级甲等综合医院检验医学微生物学组(科)建设专家共识. 中华检验医学杂志, 2016, 39(8): 581-584.
11. 马筱玲, 胡继红, 徐英春, 等. 临床微生物学实验室建设基本要求专家共识. 中华检验医学杂志, 2016, 39(11): 820-823.
12. 中国合格评定国家认可委员会. CNAS-CL02-A005: 2018医学实验室质量和能力认可准则在临床微生物检验领域的应用说明. (2018-03-01)[2020-06-01]. https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889106.shtml.
13. Barenfanger J. Quality assurances: decreasing clinically irrelevant testing from clinical microbiology laboratories, part II. Clin Microbiol Newsl, 2006, 28(4): 25-29.
14. Dellit TH, Owens RC, Mcgowan JE Jr, <italic>et al</italic>. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis, 2007, 44(2): 159-177.
15. Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am, 2014, 28(2): 177-193.
16. Oviaño M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin, 2020: S0213-005X(20)30163-4.
17. Woo PC, Lau SK, Teng JL, <italic>et al</italic>. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect, 2008, 14(10): 908-934.
18. Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother, 2020, 75(4): 968-978.
19. Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin Microbiol Infect, 2019, 25(11): 1347-1355.
20. Inglis T, Ekelund O. Rapid antimicrobial susceptibility tests for sepsis; the road ahead. J Med Microbiol, 2019, 68(7): 973-977.
21. Grohs P, Rondinaud E, Fourar M, <italic>et al</italic>. Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. J Microbiol Methods, 2020, 172: 105902.
22. Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in australian health care 2018. Sydney: Australian Commission on Safety and Quality in Health Care, 2018[2020-06-01]. https://www.safetyandquality.gov.au/publications-and-resources/resource-library/antimicrobial-stewardship-australian-health-care-2018.

Previous Article
颈胸腹骨盆会阴钢筋贯通伤医疗联合体多学科救治一例
Next Article
Progress in the laboratory detection and clinical research of cryptococcosis

West China Medical Journal

The role of clinical microbiology service in antimicrobial stewardship

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content